TETRAPHASE PHARMACEUTICALS INC Operating Cash Flow
TETRAPHASE PHARMACEUTICALS INC reported Operating Cash Flow of -$11.15 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$11.15M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$10.94M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$15.98M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$16.64M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2019 was -$63.67M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2018 was -$59.63M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2017 was -$98.05M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2013 was -$24.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 81 month | Net Cash Provided by (Used in) Operating Activities 84 month | Net Cash Provided by (Used in) Operating Activities 87 month | Net Cash Provided by (Used in) Operating Activities 90 month |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$11.15M 10-Q · filed 2020-05-07 | -$22.09M derived: sum of 2 quarters · filed 2020-05-07 | -$38.07M derived: sum of 3 quarters · filed 2020-05-07 | -$54.71M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2019-12-31 | -$10.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$26.91M derived: sum of 2 quarters · filed 2020-03-12 | -$43.55M derived: sum of 3 quarters · filed 2020-03-12 | -$63.67M 10-K · filed 2020-03-12 | ||||
| 2019-09-30 | -$15.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$32.61M derived: sum of 2 quarters · filed 2019-11-12 | -$52.73M 10-Q · filed 2019-11-12 | -$69.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2019-06-30 | -$16.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$36.76M 10-Q · filed 2019-08-08 | -$53.18M derived: sum of 3 quarters · filed 2020-05-07 | -$66.19M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2019-03-31 | -$20.12M 10-Q · filed 2020-05-07 | -$36.54M derived: sum of 2 quarters · filed 2020-05-07 | -$49.55M derived: sum of 3 quarters · filed 2020-05-07 | -$60.85M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$29.43M derived: sum of 2 quarters · filed 2020-03-12 | -$40.73M derived: sum of 3 quarters · filed 2020-03-12 | -$59.63M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | -$13.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$24.31M derived: sum of 2 quarters · filed 2019-11-12 | -$43.20M 10-Q · filed 2019-11-12 | -$69.99M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$11.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$30.20M 10-Q · filed 2019-08-08 | -$56.98M derived: sum of 3 quarters · filed 2019-08-08 | -$83.05M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$18.89M 10-Q · filed 2019-05-08 | -$45.68M derived: sum of 2 quarters · filed 2019-05-08 | -$71.75M derived: sum of 3 quarters · filed 2019-05-08 | |||||
| 2017-12-31 | -$26.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$52.86M derived: sum of 2 quarters · filed 2019-03-15 | -$98.05M 10-K · filed 2019-03-15 | |||||
| 2017-09-30 | -$26.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$71.27M 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | -$45.19M 10-Q · filed 2018-08-02 | |||||||
| 2013-12-31 | -$9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | -$17.26M derived: sum of 2 quarters · filed 2014-03-06 | -$21.95M derived: sum of 3 quarters · filed 2014-03-06 | -$24.51M 10-K · filed 2014-03-06 | -$103.93M 10-K · filed 2014-03-06 | |||
| 2013-09-30 | -$8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$12.74M derived: sum of 2 quarters · filed 2013-11-14 | -$15.30M 10-Q · filed 2013-11-14 | -$17.77M derived: sum of 4 quarters · filed 2014-03-06 | -$94.73M 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | -$4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$7.25M 10-Q · filed 2013-08-12 | -$9.71M derived: sum of 3 quarters · filed 2014-03-06 | -$13.44M derived: sum of 4 quarters · filed 2014-03-06 | -$86.67M 10-Q · filed 2013-08-12 | |||
| 2013-03-31 | -$2.56M 10-Q · filed 2013-05-13 | -$5.02M derived: sum of 2 quarters · filed 2014-03-06 | -$8.75M derived: sum of 3 quarters · filed 2014-03-06 | -$13.64M derived: sum of 4 quarters · filed 2014-03-06 | -$81.33M 10-Q · filed 2013-05-13 | |||
| 2012-12-31 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | -$6.19M derived: sum of 2 quarters · filed 2014-03-06 | -$11.09M derived: sum of 3 quarters · filed 2014-03-06 | -$16.66M 10-K · filed 2014-03-06 | ||||
| 2012-09-30 | -$3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$8.62M derived: sum of 2 quarters · filed 2013-11-14 | -$14.19M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$4.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$10.46M 10-Q · filed 2013-08-12 | ||||||
| 2012-03-31 | -$5.57M 10-Q · filed 2013-05-13 | |||||||
| 2011-12-31 | -$19.88M 10-K · filed 2014-03-06 |